English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

164 ntravesical administration of Bacille Calmette-Guérin (BCG) vaccine for the treatment of superficial transitional cell carcinoma of the bladder has been used since 1976.1 Despite its success in the prevention of cancer progression, BCG treatment can cause a number of complications. In addition to local reactions, BCG vaccine can also cause systemic adverse efHypersensitivity Reaction After Intravesical Bacille Calmette Guerin Administration for the Treatment of Bladder Carcinoma: Case Report

Hypersensitivity Reaction After Intravesical Bacille Calmette Guerin Administration For the Treatment of Bladder Carcinoma